Frontiers in Physiology,
Год журнала:
2018,
Номер
9
Опубликована: Июль 9, 2018
An
increasing
number
of
people
are
living
or
working
at
high
altitudes
(hypobaric
hypoxia)
and
therefore
suffering
several
physiological,
biochemical
molecular
changes.
Pulmonary
vasculature
is
one
the
main
first
responses
to
hypoxia.
These
imply
hypoxic
pulmonary
vasoconstriction
(HPV),
remodeling
eventually
hypertension.
events
occur
according
type
extension
exposure.
There
also
evidence
that
these
changes
in
vascular
bed
could
be
mainly
attributed
a
homeostatic
imbalance
as
result
increased
levels
reactive
oxygen
species
(ROS).
The
increase
ROS
production
during
hypobaric
hypoxia
has
been
an
enhanced
activity
expression
nicotinamide
adenine
dinucleotide
phosphate-oxidase
(NADPH
oxidase),
though
there
some
dispute
about
which
subunit
involved.
This
enzymatic
complex
may
directly
induced
by
hypoxia-inducible
factor-1α
(HIF1-α).
found
related
pathways,
cells,
enzymes
molecules
responses,
from
inflammation,
structural
changes,
such
and,
ultimately,
Therefore,
we
performed
comprehensive
review
current
on
role
development
under
conditions,
with
focus
provides
information
supporting
oxidative
stress
(mainly
ROS)
vasculature´s
depicting
possible
future
therapeutics
research
targets.
NADPH
oxidase-produced
highlighted
major
source
ROS.
Moreover,
new
molecules,
ADMA,
critical
inflammatory
cells
fibroblasts,
Several
controversies
remain
regarding
mechanisms
involved
need
elucidated.
AJP Lung Cellular and Molecular Physiology,
Год журнала:
2018,
Номер
314(5), С. L893 - L907
Опубликована: Фев. 1, 2018
Pulmonary
arterial
hypertension
(PAH)
is
a
lethal
disease
characterized
by
elevations
in
pulmonary
pressure,
part
due
to
formation
of
occlusive
lesions
the
distal
arterioles
lung.
These
complex
may
comprise
multiple
cell
types,
including
endothelial
cells
(ECs).
To
better
understand
molecular
mechanisms
underlying
EC
dysfunction
PAH,
lung
microvascular
(MVECs)
were
isolated
from
normoxic
rats
(N-MVECs)
and
subjected
SU5416
plus
hypoxia
(SuHx),
an
experimental
model
PAH.
Compared
with
N-MVECs,
MVECs
SuHx
(SuHx-MVECs)
appeared
larger
more
spindle
shaped
morphologically
expressed
canonical
smooth
muscle
markers
muscle-specific
α-actin
myosin
heavy
chain
addition
such
as
Griffonia
simplicifolia
von
Willebrand
factor.
SuHx-MVEC
mitochondria
dysfunctional,
evidenced
increased
fragmentation/fission,
decreased
oxidative
phosphorylation,
reactive
oxygen
species
(ROS)
production.
Functionally,
SuHx-MVECs
exhibited
basal
levels
intracellular
calcium
concentration
([Ca2+]i)
enhanced
migratory
proliferative
capacity.
Treatment
global
(TEMPOL)
or
mitochondria-specific
(MitoQ)
antioxidants
ROS
[Ca2]i
SuHx-MVECs.
TEMPOL
MitoQ
also
migration
proliferation
Additionally,
inhibition
ROS-induced
Ca2+
entry
via
pharmacologic
blockade
transient
receptor
potential
vanilloid-4
(TRPV4)
attenuated
[Ca2]i,
migration,
proliferation.
findings
suggest
role
for
mitochondrial
influx
TRPV4
promoting
abnormal
this
PAH
model.
Hypertension,
Год журнала:
2015,
Номер
66(6), С. 1227 - 1239
Опубликована: Окт. 6, 2015
A
recent
study
demonstrated
a
significant
role
for
leukotriene
B4
(LTB4)
causing
pulmonary
vascular
remodeling
in
arterial
hypertension.
LTB4
was
found
to
directly
injure
luminal
endothelial
cells
and
promote
growth
of
the
smooth
muscle
cell
layer
arterioles.
The
purpose
this
determine
effects
on
adventitial
layer,
largely
composed
fibroblasts.
Here,
we
demonstrate
that
enhanced
human
artery
fibroblast
proliferation,
migration,
differentiation
dose-dependent
manner
through
its
cognate
G-protein-coupled
receptor,
BLT1.
activated
by
upregulating
p38
mitogen-activated
protein
kinase
as
well
Nox4-signaling
pathways.
In
an
autoimmune
model
hypertension,
inhibition
these
pathways
blocked
perivascular
inflammation,
decreased
Nox4
expression,
reduced
reactive
oxygen
species
production,
reversed
arteriolar
activation,
attenuated
hypertension
development.
This
uncovers
novel
mechanism
which
further
promotes
pathogenesis,
beyond
established
cells,
activating
Abstract
Galangin,
a
natural
flavonol,
has
attracted
much
attention
for
its
potential
anti-inflammatory
properties.
However,
role
in
the
regulation
of
airway
remodelling
asthma
not
been
explored.
The
present
study
aimed
to
elucidate
effects
galangin
on
chronic
inflammation
and
investigate
underlying
mechanisms
both
vivo
vitro
.
Ovalbumin
(OVA)-sensitised
mice
were
administered
with
30
min
before
challenge.
Our
results
showed
that
severe
inflammatory
responses
occurred
OVA-induced
mice.
Treatment
markedly
attenuated
leakage
cells
into
bronchoalveolar
lavage
fluid
(BALF)
decreased
level
OVA-specific
IgE
serum.
Galangin
significantly
inhibited
goblet
cell
hyperplasia,
collagen
deposition
α-SMA
expression.
Lowered
TGF-β1
suppressed
expression
VEGF
MMP-9
observed
BALF
or
lung
tissue,
implying
an
optimal
anti-remodelling
effect
Consistently,
TGF-β1-induced
proliferation
smooth
muscle
was
reduced
by
,
which
might
be
due
alleviation
ROS
levels
inhibition
MAPK
pathway.
Taken
together,
findings
highlight
novel
as
promising
agent
asthma,
likely
involves
TGF-β1-ROS-MAPK
International Journal of Biological Sciences,
Год журнала:
2017,
Номер
13(8), С. 1067 - 1081
Опубликована: Янв. 1, 2017
The
endothelial-to-mesenchymal
transition
(EndMT)
has
been
demonstrated
to
be
involved
in
pulmonary
vascular
remodeling.It
is
partly
attributed
oxidative
and
inflammatory
stresses
endothelial
cells.In
current
study,
we
conducted
a
series
of
experiments
clarify
the
effect
salvianolic
acid
A
(SAA),
kind
polyphenol
compound,
process
EndMT
human
arterial
cells
vivo
therapeutic
efficacy
on
remodeling
monocrotaline
(MCT)-induced
EndMT.EndMT
was
induced
by
TGFβ1
(HPAECs).SAA
significantly
attenuated
EndMT,
simultaneously
inhibited
cell
migration
reactive
oxygen
species
(ROS)
formation.In
MCT-induced
hypertension
(PAH)
model,
SAA
improved
function,
decreased
level
inflammation.Mechanistically,
stimulated
Nrf2
translocation
subsequent
heme
oxygenase-1
(HO-1)
up-regulation.The
vitro
abolished
ZnPP,
HO-1
inhibitor.In
conclusion,
this
study
indicates
deleterious
impact
stress
EndMT.Polyphenol
antioxidant
treatment
may
provide
an
adjunctive
action
alleviate
via
inhibiting
EndMT.
International Journal of Molecular Sciences,
Год журнала:
2021,
Номер
22(9), С. 4980 - 4980
Опубликована: Май 7, 2021
Pulmonary
hypertension
is
defined
as
a
group
of
diseases
characterized
by
progressive
increase
in
pulmonary
vascular
resistance
(PVR),
which
leads
to
right
ventricular
failure
and
premature
death.
There
are
multiple
clinical
manifestations
that
can
be
grouped
into
five
different
types.
artery
remodeling
common
feature
(PH)
endothelial
dysfunction
smooth
muscle
cell
proliferation.
The
current
treatments
for
PH
limited
vasodilatory
agents
do
not
stop
the
progression
disease.
Therefore,
there
need
new
inhibit
targeting
main
genetic,
molecular,
cellular
processes
involved
PH.
Chronic
inflammation
contributes
PH,
among
other
disorders,
many
inflammatory
mediators
signal
through
JAK/STAT
pathway.
Recent
evidence
indicates
pathway
overactivated
arteries
patients
with
In
addition,
profibrotic
cytokines
such
IL-6,
IL-13,
IL-11
growth
factors
PDGF,
VEGF,
TGFβ1
activators
inducers
remodeling,
thus
participating
development
understanding
participation
modulation
could
an
attractive
strategy
developing
future
treatments.
have
been
no
studies
date
focused
on
this
review,
we
focus
analysis
expression
distribution
isoforms
types
Furthermore,
molecular
canonical
noncanonical
transactivation
will
discussed
context
consequences
activation
cells
cells’
proliferation,
migration,
senescence,
transformation
mesenchymal/myofibroblast
described
discussed,
together
promising
drugs
vitro
vivo.
Physiological Reviews,
Год журнала:
2022,
Номер
103(3), С. 1827 - 1897
Опубликована: Ноя. 24, 2022
The
pulmonary
circulation
is
a
low-resistance,
low-pressure,
and
high-compliance
system
that
allows
the
lungs
to
receive
entire
cardiac
output.
Pulmonary
arterial
pressure
function
of
output
vascular
resistance,
resistance
inversely
proportional
fourth
power
intraluminal
radius
artery.
Therefore,
very
small
decrease
lumen
diameter
results
in
significant
increase
pressure.
hypertension
fatal
progressive
disease
with
poor
prognosis.
Regardless
initial
pathogenic
triggers,
sustained
vasoconstriction,
concentric
remodeling,
occlusive
intimal
lesions,
situ
thrombosis,
wall
stiffening
are
major
direct
causes
for
elevated
patients
other
forms
precapillary
hypertension.
In
this
review,
we
aim
discuss
basic
principles
physiological
mechanisms
involved
regulation
lung
hemodynamics
function,
changes
vasculature
contribute
increased
pressure,
development
progression
We
focus
on
reviewing
roles
membrane
receptors,
ion
channels,
intracellular
Ca
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Май 5, 2023
Hypoxic
pulmonary
hypertension
(HPH)
is
a
complicated
vascular
disorder
characterized
by
diverse
mechanisms
that
lead
to
elevated
blood
pressure
in
circulation.
Recent
evidence
indicates
HPH
not
simply
pathological
syndrome
but
instead
complex
lesion
of
cellular
metabolism,
inflammation,
and
proliferation
driven
the
reprogramming
gene
expression
patterns.
One
key
underlying
hypoxia,
which
drives
immune/inflammation
mediate
homeostasis
collaboratively
controls
remodeling
lungs.
This
caused
prolonged
infiltration
immune
cells
an
increase
several
pro-inflammatory
factors,
ultimately
leads
dysregulation.
Hypoxia
has
been
associated
with
metabolic
reprogramming,
immunological
dysregulation,
adverse
preclinical
studies.
Many
animal
models
have
developed
mimic
HPH;
however,
many
them
do
accurately
represent
human
disease
state
may
be
suitable
for
testing
new
therapeutic
strategies.
The
scientific
understanding
rapidly
evolving,
recent
efforts
focused
on
interplay
among
metabolism
development
this
disease.
Through
continued
research
more
sophisticated
models,
it
hoped
we
will
able
gain
deeper
implement
effective
therapies
debilitating
BMC Pulmonary Medicine,
Год журнала:
2015,
Номер
15(1)
Опубликована: Май 1, 2015
Oxidative
stress
(OS)
and
reduced
nitric
oxide
(NO)
bioavailability
contribute
to
the
pathogenesis
of
pulmonary
hypertension
(PH).
Whether
there
are
associations
between
OS
NO
signaling
biomarkers
whether
these
associated
with
severity
PH
remain
unclear.
Blood
samples
were
collected
from
35
healthy
controls
patients
arterial
(PAH,
n
=
12)
or
chronic
thromboembolic
(CTEPH,
23).
The
mean
artery
pressure
(mPAP)
vascular
resistance
index
(PVRI)
measured
by
right
heart
catheterization.
We
derivative
reactive
oxygen
molecules
(d-ROMs),
biological
antioxidant
potential
(BAP)
superoxide
dismutase
(SOD)
automatic
biochemical
analyzer,
malondialdehyde
(MDA)
asymmetric
dimethylarginine
(ADMA)
enzyme-linked
immunosorbent
assay.
relationship
oxidative-antioxidative
ADMA,
as
well
their
association
hemodynamics,
analyzed.
Compared
age-
gender-matched
controls,
was
no
significant
difference
d-ROMs
in
PAH
CTEPH
patients;
MDA
increased
(P
0.034);
BAP
SOD
decreased
0.014,
P
<
0.001)
0.015,
0.001);
ADMA
level
significantly
higher
0.007)
0.001).
No
found.
Serum
concentration
correlated
mPAP
(r
0.762,
0.006)
PVRI
0.603,
0.038)
patients.
antioxidative
impaired
CTEPH.
Increased
serum
is
unfavorable
hemodynamics
Thus,
may
be
useful
evaluation
risk
stratification
PAH.